Navigation Links
The Michael J. Fox Foundation Announces Fourth Quarter Participants in Partnering Program Between Awardees and Industry
Date:11/15/2012

NEW YORK, Nov. 15, 2012 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation (MJFF) has announced fourth-quarter 2012 participants in its Partnering Program. Selected from the most promising research projects in the MJFF portfolio, Partnering Program participants' research projects are presented directly to industry groups who may wish to invest in further development of the project. By connecting industry leaders with those projects ripe for investment, the Foundation aims to drive forward promising projects in PD research through the pipeline of drug development, and eventually into patients' hands.

Non-confidential overviews of select MJFF-funded projects are shared with industry contacts and more broadly via MJFF's Web site on a quarterly basis.

MJFF-supported projects featured in Q4 include:

  • SynAgile is developing DopaFuse, a levodopa prodrug which is continuously, subcutaneously infused using a simple insulin infusion pump.  It is designed to reduce motor fluctuations in people with PD.
  • Durin Technologies has completed work to determine if using specific autoantibodies as diagnostic biomarkers for full-blown Parkinson's could also be used for early detection of PD.
  • Sapiens is working on technology to more accurately stimulate intended therapeutic brain structures in Deep Brain Stimulation, toward improving therapeutic outcomes and reducing side effects for Parkinson's patients. 

Overviews from awardees PsychoGenics and Gliacor Therapeutics were showcased in Q3 2012.

To date, the Foundation has funded over $304 million in research, over $81 million of which has been directed to more than 170 unique projects led by industry partners.

To view the Q4 2012 participants, and all MJFF awardees featured via the Partnering Program thus far, visit the Partnering Program page at https://www.michaeljfox.org/research/opportunities-for-industry/partnering-program.html.

To find out more, please contact the MJFF Research Partnerships team at ResearchPartnerships@michaeljfox.org.


'/>"/>
SOURCE The Michael J. Fox Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
2. Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
3. Avaxia Biologics Announces Appointment of Michael D. Rivard as VP Corporate Development
4. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
5. The Michael J. Fox Foundation Launches The $14 Million-Edmond J. Safra Core Programs for PD Research
6. Response to U.S. Supreme Courts Healthcare Decision by Michael Zamagias, Chairman, TeleTracking Technologies
7. Lilly Announces Retirement of Robert Armitage, Names Michael Harrington Senior Vice President and General Counsel
8. AMRI Appoints Michael Nolan Vice President, Chief Financial Officer and Treasurer
9. Michael F. Mahoney Assumes Role of Chief Executive Officer and President of Boston Scientific
10. Michael Epstein joins MedSpan Research as Director, Research Services
11. American Academy of Family Physicians Foundation Launches Cities for Life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Feb. 21, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Liver Cirrhosis Drugs Price Analysis and ... Liver Cirrhosis market. The research answers the following questions: ... and their clinical attributes? How are they positioned in the Global Liver ...
(Date:2/20/2017)... Feb. 20, 2017 EU5 Magnetic Resonance Imaging (MRI) Systems ... ... Resonance Imaging (MRI) Systems Market Outlook to 2022", provides key market ... report provides value, in millions of US dollars, volume (in units) ... and 1.5T MRI Systems. The report also provides ...
(Date:2/20/2017)... , Feb. 20, 2017  This Report analyzes the worldwide ... Dosage Forms: Injectables, Solid Dosage Forms, and Liquid & Semi-solid Dosage ... Canada , Japan , ... World. Read the full report: http://www.reportlinker.com/p04707109-summary/view-report.html ... Annual estimates ...
Breaking Medicine Technology:
(Date:2/21/2017)... ... February 21, 2017 , ... Individuals who have been diagnosed ... surgery, treatment, therapy and management. Regular exercise in proper environments has been shown ... their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx ...
(Date:2/21/2017)... Ga. (PRWEB) , ... February 21, 2017 , ... Support ... To simplify the secure exchange of data across industry solutions, Fogo Data Centers ... the power of community. A healthy community is one in which all systems ...
(Date:2/21/2017)... Doylestown, Pa. (PRWEB) , ... ... ... leading provider of technology-enabled clinical trial solutions, today announced the further expansion ... types of applications they can leverage as part of Bioclinica’s extensive and ...
(Date:2/21/2017)... GA (PRWEB) , ... February 21, 2017 , ... ... announced the acquisition of the predictive analytic firm Predixion’s Healthcare IT practice. Predixion, ... investment and is backed by giants including Accenture, GE Ventures, and ...
(Date:2/21/2017)... ... February 21, 2017 , ... One ... untreated despite the medical, mental health, and financial consequences of inaction. On March ... take action if they have concerns about their hearing. , Effective treatment in ...
Breaking Medicine News(10 mins):